CoChat

Probabilistic disease progression modeling to characterize diagnostic uncertainty: Application to staging and prediction in Alzheimer's disease

Open access
Lorenzi, Marco, Filippone, Maurizio, Frisoni, Giovanni B., Alexander, Daniel C., Ourselin, Sebastien · 2019 · NeuroImage
Cited by 135

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Disease progression modeling (DPM) of Alzheimer's disease (AD) aims at revealing long term pathological trajectories from short term clinical data. Along with the ability of providing a data‐driven description of the natural evolution of the pathology, DPM has the potential of representing a valuable clinical instrument for automatic diagnosis, by explicitly describing the biomarker transition from normal to pathological stages along the disease time axis. In this work we reformulated DPM within a probabilistic setting to quantify the diagnostic uncertainty of individual disease severity in an hypothetical clinical scenario, with respect to missing measurements, biomarkers, and follow‐up information. We show that the staging provided by the model on 582 amyloid positive testing individuals has high face validity with respect to the clinical diagnosis. Using follow‐up measurements largely reduces the prediction uncertainties, while the transition from normal to pathological stages is mostly associated with the increase of brain hypo‐metabolism, temporal atrophy, and worsening of clinical scores. The proposed formulation of DPM provides a statistical reference for the accurate probabilistic assessment of the pathological stage of de‐novo individuals, and represents a valuable instrument for quantifying the variability and the diagnostic value of biomarkers across disease stages.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuroimage.2017.08.059

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 21

  1. Guerrero, 2016, Instantiated mixed effects modeling of Alzheimer's disease markers, NeuroImage, 142, 113, 10.1016/j.neuroimage.2016.06.049 · DOI
  2. Henneman, 2009, Hippocampal atrophy rates in Alzheimer's disease. added value over whole brain volume measures, Neurology, 72, 999, 10.1212/01.wnl.0000344568.09360.31 · DOI · Paper page
  3. Hill, 2014, Coalition against major diseases/european medicines agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's disease, Alzheimer’s Dementia, 10, 421, 10.1016/j.jalz.2013.07.003 · DOI · Paper page
  4. Jack, 2016, Suspected non-Alzheimer disease pathophysiology – concept and controversy, Nat. Rev. Neurol., 12, 117, 10.1038/nrneurol.2015.251 · DOI · Paper page
  5. Jedynak, 2012, A computational neurodegenerative disease progression score: method and results with the Alzheimer's disease neuroimaging initiative cohort, Neuroimage, 63, 1478, 10.1016/j.neuroimage.2012.07.059 · DOI · Paper page
  6. Joensuu, 2012, Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts, Lancet Oncol., 13, 265, 10.1016/S1470-2045(11)70299-6 · DOI · Paper page
  7. Kneip, 1988, Convergence and consistency results for self-modeling nonlinear regression, Ann. Statistics, 82
  8. Lázaro-Gredilla, 2012, Overlapping mixtures of Gaussian processes for the data association problem, Pattern Recognit., 45, 1386, 10.1016/j.patcog.2011.10.004 · DOI
  9. Liu, 2010, Estimating replicate time shifts using Gaussian process regression, Bioinformatics, 26, 770, 10.1093/bioinformatics/btq022 · DOI
  10. Lorenzi, 2010, Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment, Neurobiol. Aging, 31, 1443, 10.1016/j.neurobiolaging.2010.04.036 · DOI · Paper page
  11. Lorenzi, 2016, Multimodal image analysis in Alzheimer's disease via statistical modelling of non-local intensity correlations, Sci. Rep., 6, 22161, 10.1038/srep22161 · DOI
  12. McKhann, 1984, Clinical diagnosis of alzheimer's disease report of the nincds-adrda work group* under the auspices of department of health and human services task force on alzheimer's disease, Neurology, 34, 10.1212/WNL.34.7.939 · DOI · Paper page
  13. Mendelson, 2016, Selection bias in the reported performances of AD classification pipelines, NeuroImage Clin., 14, 400, 10.1016/j.nicl.2016.12.018 · DOI · Paper page
  14. Mormino, 2016, Heterogeneity in suspected non–Alzheimer disease pathophysiology among clinically normal older individuals, Jama Neurol., 73, 1185, 10.1001/jamaneurol.2016.2237 · DOI · Paper page
  15. Nickisch, 2008, Approximations for binary Gaussian process classification, J. Mach. Learn. Res., 9, 2035
  16. Riihimäki, 2010, Gaussian processes with monotonicity information, vol. 9, 645
  17. Shinkins, 2013, Diagnostic uncertainty: dichotomies are not the answer, Br. J. General Pract., 63, 122, 10.3399/bjgp13X664090 · DOI
  18. Wolz, 2010, Measurement of hippocampal atrophy using 4D graph-cut segmentation: application to ADNI, NeuroImage, 52, 109, 10.1016/j.neuroimage.2010.04.006 · DOI
  19. Yang, 2011, Quantifying the pathophysiological timeline of Alzheimer's disease, J. Alzheimer’s Dis., 26, 745, 10.3233/JAD-2011-110551 · DOI · Paper page
  20. Younes, 2014, Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease, NeuroImage Clin., 5, 178, 10.1016/j.nicl.2014.04.009 · DOI
  21. Yu, 2014, Operationalizing hippocampal volume as an enrichment biomarker for amnestic mild cognitive impairment trials: effect of algorithm, test-retest variability, and cut point on trial cost, duration, and sample size, Neurobiol. Aging, 35, 808, 10.1016/j.neurobiolaging.2013.09.039 · DOI · Paper page

Cited by

See all 135

Metadata

Authors
Lorenzi, M., Filippone, M., Frisoni, G. B., Alexander, D. C., & Ourselin, S.
Venue
NeuroImage
Publisher
Elsevier BV
Published
2019-04
Volume
190
Pages
56-68
ISSN
1053-8119 (ISSN-L)
OpenAlex
W2577478840
Cited by
135
References
12
FWCI
9.17
Type
journal article
Language
en
Open access
bronze
Licence
Funders
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
  • IXICO
  • Alzheimer's Drug Discovery Foundation
  • Alzheimer's Disease Neuroimaging Initiative
  • Eli Lilly and Company
  • BioClinica
  • Genentech
  • Fujirebio Europe
  • AbbVie
  • Horizon 2020 (666992)
  • Alzheimer's Association
  • GE Healthcare
  • H. Lundbeck A/S
  • National Institutes of Health (U01 AG024904)
  • Janssen Research and Development
  • AXA Research Fund
  • U.S. Department of Defense (W81XWH-12-2-0012)
  • Biogen
  • Eisai
  • National Institute on Aging
  • University of Southern California
  • National Institute of Biomedical Imaging and Bioengineering
  • University of California, San Diego
  • Johnson and Johnson
  • Northern California Institute for Research and Education
  • Merck
  • Engineering and Physical Sciences Research Council (EP/J020990/01, EP/M020533/1)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Probabilistic disease progression modeling to characterize diagnostic uncertainty: Application to staging and prediction in Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.neuroimage.2017.08.059
The paper
Lorenzi, M., Filippone, M., Frisoni, G. B., Alexander, D. C., & Ourselin, S. (2019). Probabilistic disease progression modeling to characterize diagnostic uncertainty: Application to staging and prediction in Alzheimer's disease. NeuroImage. https://doi.org/10.1016/j.neuroimage.2017.08.059

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.